NO900019L - Piperidiner og fremgangsmaate til fremstilling derav. - Google Patents
Piperidiner og fremgangsmaate til fremstilling derav.Info
- Publication number
- NO900019L NO900019L NO90900019A NO900019A NO900019L NO 900019 L NO900019 L NO 900019L NO 90900019 A NO90900019 A NO 90900019A NO 900019 A NO900019 A NO 900019A NO 900019 L NO900019 L NO 900019L
- Authority
- NO
- Norway
- Prior art keywords
- group
- fluorobenzoyl
- piperidyl
- piperidines
- nitrogen atom
- Prior art date
Links
- 150000003053 piperidines Chemical class 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- -1 4-fluorobenzoyl Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- KZKRRZFCAYOXQE-UHFFFAOYSA-N 1$l^{2}-azinane Chemical compound C1CC[N]CC1 KZKRRZFCAYOXQE-UHFFFAOYSA-N 0.000 abstract 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8900071A FR2641278B1 (fr) | 1989-01-05 | 1989-01-05 | Piperidines, procedes de preparation et medicaments les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO900019D0 NO900019D0 (no) | 1990-01-04 |
| NO900019L true NO900019L (no) | 1990-07-06 |
Family
ID=9377487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90900019A NO900019L (no) | 1989-01-05 | 1990-01-04 | Piperidiner og fremgangsmaate til fremstilling derav. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5001134A (de) |
| EP (1) | EP0377528B1 (de) |
| JP (1) | JP2927480B2 (de) |
| AT (1) | ATE98231T1 (de) |
| AU (1) | AU634739B2 (de) |
| CA (1) | CA2007127A1 (de) |
| DD (1) | DD291323A5 (de) |
| DE (1) | DE69004973T2 (de) |
| DK (1) | DK0377528T3 (de) |
| ES (1) | ES2062425T3 (de) |
| FR (1) | FR2641278B1 (de) |
| HU (1) | HUT58053A (de) |
| IL (1) | IL92950A0 (de) |
| MA (1) | MA21719A1 (de) |
| MX (1) | MX26760A (de) |
| NO (1) | NO900019L (de) |
| NZ (1) | NZ232023A (de) |
| OA (1) | OA09433A (de) |
| PT (1) | PT92782A (de) |
| RU (1) | RU1838299C (de) |
| TN (1) | TNSN90002A1 (de) |
| YU (1) | YU2290A (de) |
| ZA (1) | ZA9061B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5364866A (en) * | 1989-05-19 | 1994-11-15 | Hoechst-Roussel Pharmaceuticals, Inc. | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
| US5776963A (en) * | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
| US5561128A (en) * | 1989-05-19 | 1996-10-01 | Hoechst-Roussel Pharmaceuticals, Inc. | N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility |
| US5378714A (en) * | 1991-11-27 | 1995-01-03 | Novo Nordisk A/S | Antipsychotic piperidine derivatives |
| NZ245260A (en) * | 1991-11-27 | 1995-06-27 | Novo Nordisk As | Piperidine derivatives, preparation and pharmaceutical compositions thereof |
| AU4984293A (en) * | 1992-09-17 | 1994-04-12 | Nippon Soda Co., Ltd. | Nitrogenous heterocyclic compound, process for producing the same, and pest control agent |
| US5512591A (en) * | 1993-02-18 | 1996-04-30 | President And Fellows Of Harvard College | Treatments for diseases characterized by neovascularization |
| US5633274A (en) * | 1993-02-18 | 1997-05-27 | President And Fellows Of Harvard College | Cancer treatments |
| DK60793D0 (da) * | 1993-05-26 | 1993-05-26 | Novo Nordisk As | Kemiske forbindelser, deres fremstilling og anvendelse |
| DK60693D0 (da) * | 1993-05-26 | 1993-05-26 | Novo Nordisk As | Kemiske forbindelser, deres fremstilling og anvendelse |
| DK60593D0 (da) * | 1993-05-26 | 1993-05-26 | Novo Nordisk As | Kemiske forbindelser, deres fremstilling og anvendelse |
| DK60893D0 (da) * | 1993-05-26 | 1993-05-26 | Novo Nordisk As | Piperidinderivater, deres fremstilling og anvendelse |
| US5453425A (en) * | 1994-07-11 | 1995-09-26 | Janssen Pharmaceutica N.V. | Risperidone oral formulation |
| US5556871A (en) * | 1995-04-24 | 1996-09-17 | President & Fellows Of Harvard College | Method for treating epithelial precancerous lesions with topical inidazoles |
| EP1156807A4 (de) * | 1998-12-18 | 2002-04-03 | Du Pont Pharm Co | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren |
| AU2057200A (en) * | 1998-12-18 | 2000-07-03 | Du Pont Pharmaceuticals Company | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| CA2347909A1 (en) * | 1998-12-18 | 2000-06-22 | Joseph B. Santella, Iii | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| US6605623B1 (en) * | 1998-12-18 | 2003-08-12 | Bristol-Myers Squibb Pharma Co. | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| IL151533A0 (en) * | 2000-02-29 | 2003-04-10 | Mitsubishi Pharma Corp | Novel cyclic amide derivatives |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4355037A (en) * | 1981-11-12 | 1982-10-19 | Hoechst-Roussel Pharmaceuticals | 3-(4-Piperidyl)-1,2-benzisoxales |
| FR2527205A1 (fr) * | 1982-05-18 | 1983-11-25 | Bouchara Emile | Nouvelles phenyloxoalcoyl piperidines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant |
| US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
-
1989
- 1989-01-05 FR FR8900071A patent/FR2641278B1/fr not_active Expired - Lifetime
-
1990
- 1990-01-02 IL IL92950A patent/IL92950A0/xx unknown
- 1990-01-03 MA MA21979A patent/MA21719A1/fr unknown
- 1990-01-03 ES ES90400006T patent/ES2062425T3/es not_active Expired - Lifetime
- 1990-01-03 DK DK90400006.4T patent/DK0377528T3/da active
- 1990-01-03 AT AT90400006T patent/ATE98231T1/de not_active IP Right Cessation
- 1990-01-03 DE DE69004973T patent/DE69004973T2/de not_active Expired - Fee Related
- 1990-01-03 EP EP90400006A patent/EP0377528B1/de not_active Expired - Lifetime
- 1990-01-04 JP JP2000045A patent/JP2927480B2/ja not_active Expired - Lifetime
- 1990-01-04 RU SU904742892A patent/RU1838299C/ru active
- 1990-01-04 ZA ZA9061A patent/ZA9061B/xx unknown
- 1990-01-04 DD DD90336942A patent/DD291323A5/de not_active IP Right Cessation
- 1990-01-04 PT PT92782A patent/PT92782A/pt unknown
- 1990-01-04 MX MX2676090A patent/MX26760A/es unknown
- 1990-01-04 HU HU9039A patent/HUT58053A/hu unknown
- 1990-01-04 NO NO90900019A patent/NO900019L/no unknown
- 1990-01-04 CA CA002007127A patent/CA2007127A1/fr not_active Abandoned
- 1990-01-05 US US07/461,515 patent/US5001134A/en not_active Expired - Lifetime
- 1990-01-05 AU AU47713/90A patent/AU634739B2/en not_active Expired - Fee Related
- 1990-01-05 YU YU00022/90A patent/YU2290A/xx unknown
- 1990-01-05 TN TNTNSN90002A patent/TNSN90002A1/fr unknown
- 1990-01-05 OA OA59722A patent/OA09433A/xx unknown
- 1990-01-05 NZ NZ232023A patent/NZ232023A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH02225465A (ja) | 1990-09-07 |
| HU900039D0 (en) | 1990-03-28 |
| YU2290A (en) | 1992-05-28 |
| HUT58053A (en) | 1992-01-28 |
| EP0377528B1 (de) | 1993-12-08 |
| FR2641278B1 (fr) | 1991-03-22 |
| AU4771390A (en) | 1990-07-12 |
| MA21719A1 (fr) | 1990-10-01 |
| JP2927480B2 (ja) | 1999-07-28 |
| ES2062425T3 (es) | 1994-12-16 |
| MX26760A (es) | 1994-02-28 |
| DK0377528T3 (da) | 1994-04-11 |
| RU1838299C (ru) | 1993-08-30 |
| NO900019D0 (no) | 1990-01-04 |
| CA2007127A1 (fr) | 1990-07-05 |
| US5001134A (en) | 1991-03-19 |
| FR2641278A1 (fr) | 1990-07-06 |
| NZ232023A (en) | 1992-05-26 |
| AU634739B2 (en) | 1993-03-04 |
| EP0377528A1 (de) | 1990-07-11 |
| PT92782A (pt) | 1990-07-31 |
| DD291323A5 (de) | 1991-06-27 |
| DE69004973D1 (de) | 1994-01-20 |
| ZA9061B (en) | 1990-10-31 |
| ATE98231T1 (de) | 1993-12-15 |
| DE69004973T2 (de) | 1994-06-23 |
| TNSN90002A1 (fr) | 1991-03-05 |
| OA09433A (fr) | 1992-10-15 |
| IL92950A0 (en) | 1990-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO900019D0 (no) | Piperidiner og fremgangsmaate til fremstilling derav. | |
| DK0646115T3 (da) | Heterocykliske/cykliske aminderivater | |
| DK131893D0 (da) | 2-(substitueret methyl)-4-(substitueret ethoxy)-5-(lavere alkyl)-pyridinforbindelser, farmaceutisk praeparat, som indeholder saadanne samt anvendelse af en saadan forbindelse til fremstilling af et farmaceutisk praeparat | |
| BR1100931A (pt) | Compostos derivados de aril-heteroaril carbinóis, processos para a preparação dos compostos, composições farmacêuticas, e, uso dos compostos derivados de aril-heteroaril carbinóis | |
| DK0687253T3 (da) | Hidtil ukendte 4-aminopyridiner, fremgangsmåde til deres fremstilling samt lægemidler indeholdende disse forbindelser | |
| FI952850A7 (fi) | Menetelmä lääkeaineena käyttökelpoisen syklisen amiiniyhdisteen tai sen farmaseuttisen suolan valmistamiseksi | |
| ATE96437T1 (de) | (1-hydroxy-2-piperidinylalkyl)-2-indolon, 2quinolinon, 2-benzo(b>azepinon, 2-benzimidazolon und 2-quinazolinon-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung. | |
| DE69522945D1 (de) | Verbindungen, die als antiproliferative mittel und als garft inhibitoren verwendbar sind | |
| CA2238817A1 (en) | 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives | |
| AR012102A1 (es) | Derivados de 2-(iminometil)amino-fenilo, su preparacion, uso de los mismos para la fabricacion de medicamentos y composiciones farmaceuticas que los contienen. | |
| ATE101612T1 (de) | Serotonin-antagonisten, ihre herstellung und sie enthaltende arzneimittel. | |
| KR930004262A (ko) | 메타노안트라센 화합물 | |
| ATE128463T1 (de) | Piperidin und pyrrolidin derivate. | |
| CY1105208T1 (el) | Ετepοαρυλ παραγωγα σαν ανωτepοι συνδετηρες για τον υποδοχεα nociceptin orl-1 | |
| DK0461958T3 (da) | 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapien | |
| KR930004234A (ko) | 메타노안트라센 화합물 | |
| NO981814L (no) | Nye heterocykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger som inneholder dem | |
| KR930700441A (ko) | 1-피페리디닐 알카노일아릴 술폰아미드 유도체 | |
| ATE92058T1 (de) | Pyrimidin-derivate, 2-(4-(alpha-heteroaryl-alphaaryl-(alpha-alkyl)-methoxy)-butyl)-1-piperaziny > mit serotoninergischer wirkung. | |
| DK104388D0 (da) | Hidtil ukendte 2-(2,3-dihydro-2-oxo-3-benzofuranyl)-eddikesyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem | |
| NO871140D0 (no) | Fremgangsmaate ved fremstilling av nye 1- (3-(2-(4-morfolinyl)-etoksy)-(2-dialkylaminoetoksy)-2-tienyl)-3-fenyl-propanoner og syreaddisjonssalter derav. |